Prostate Biposy Melbourne

What is a prostate biopsy?

A prostate biopsy is a procedure used to take small samples of tissue from the prostate. These samples are examined under a microscope to check for prostate cancer or other abnormalities.

A biopsy is usually considered as part of a broader assessment rather than in isolation. PSA levels, prostate MRI findings, examination findings, family history, age, and overall clinical context all help determine whether a biopsy is appropriate and how it should be performed.

For many patients, the biopsy itself is only one part of the process. Just as important is understanding why a biopsy may be recommended, what the results mean, and what happens next.

When might a prostate biopsy be recommended?

A prostate biopsy may be recommended when there is concern about the possibility of prostate cancer. This may happen in situations such as:

• an elevated PSA

• a rising PSA over time

• an abnormal prostate MRI

• an abnormal prostate examination

• other clinical findings that suggest further investigation is needed

Not every elevated PSA means a biopsy is automatically required. PSA can be affected by several factors, and decisions about biopsy should be made carefully. In some cases, further assessment, repeat testing, or monitoring may be appropriate before proceeding to biopsy.

This is where specialist urological assessment becomes important. The goal is not simply to order a procedure, but to understand the whole picture and recommend the most appropriate next step.

The role of PSA, MRI, and specialist assessment

PSA testing can help identify men and people with prostates who may need further assessment, but PSA alone does not diagnose prostate cancer.

Prostate MRI has become an important part of modern prostate assessment. It can help identify suspicious areas within the prostate and may guide whether biopsy is recommended and how the biopsy should be targeted.

A careful review of PSA results, MRI findings, symptoms, examination findings, personal risk factors, and overall health helps create a clearer picture. This allows biopsy decisions to be based on more than a single number or test result.

How Dr Deanne approaches prostate biopsy decisions

For many patients, the most difficult part is not the procedure itself, but understanding whether a biopsy is needed and what the result may mean.

Dr Deanne takes a careful, thorough, and no-judgement approach to prostate assessment. Consultations are designed to give patients clear advice, space for honest questions, and respectful discussion around sensitive concerns. This includes not only the clinical aspects of PSA, MRI, and biopsy results, but also the uncertainty and anxiety that often come with possible prostate cancer.

Rather than rushing patients into a procedure, the focus is on understanding the reason for biopsy, explaining the potential benefits and limitations, and helping each patient feel informed about the decision being made.

Patients often value:

• careful review of PSA and MRI findings

• clear explanation of why biopsy is or is not being recommended

• respectful, no-pressure discussion

• space for sensitive conversations without pressure or judgement

• guidance on what the result could mean for treatment or monitoring

How is a prostate biopsy performed?

A prostate biopsy is commonly performed using a transperineal approach. This means the biopsy needles pass through the skin between the scrotum and the anus (the perineum) to obtain tissue samples from the prostate.

In modern prostate biopsy practice, the procedure may involve:

• targeted biopsy, where samples are taken from areas that appear suspicious on MRI

• systematic biopsy, where samples are taken from different parts of the prostate in a structured way

Depending on the clinical setting and procedure plan, biopsy may be performed under appropriate anaesthetic arrangements. Specific instructions are provided before the procedure so patients know how to prepare and what to expect.

Why transperineal biopsy is commonly preferred

Transperineal prostate biopsy is widely used in contemporary urological practice and is commonly preferred over the older transrectal approach.

Potential advantages of the transperineal approach include:

• lower infection risk compared with transrectal biopsy

• effective access to different parts of the prostate

• ability to combine MRI-targeted and systematic sampling where appropriate

This approach forms part of modern, evidence-based prostate cancer diagnosis and can help improve both safety and diagnostic accuracy.

What to expect on the day

Before the biopsy, patients are given instructions about preparation, medications, and the practical details of the procedure.

On the day, the process generally includes:

• admission or arrival at the procedure location

• review of relevant medical information

• the biopsy itself

• a period of recovery and observation before going home

Patients are also advised about what to expect afterwards, including common temporary symptoms, recovery, and when to seek medical attention.

Clear pre-procedure and post-procedure guidance can make the experience more predictable and less stressful.

Recovery, side effects, and risks

Most patients recover without major problems, but it is important to understand the common side effects and possible risks of prostate biopsy.

Common temporary effects may include:

• blood in the urine

• blood in the semen

• mild discomfort or bruising

• temporary urinary symptoms

Less commonly, patients may experience:

• difficulty passing urine

• urinary retention

• infection

• bleeding that is more significant than expected

Although infection risk is generally lower with transperineal biopsy than with older transrectal techniques, patients should still follow all post-procedure instructions and seek medical advice if they develop fever, worsening pain, difficulty passing urine, or other concerning symptoms.

Open discussion of risks is an important part of informed decision-making.

Understanding the biopsy results

Biopsy results are interpreted alongside PSA, MRI findings, examination findings, and the broader clinical picture.

A prostate biopsy may show:

• no cancer

• low-grade or low-risk prostate cancer

• clinically significant prostate cancer that may need treatment discussion

A positive biopsy does not automatically mean surgery is required. Some patients may be suitable for active surveillance, while others may benefit from treatment such as surgery or radiation-based management depending on the nature of the cancer and individual priorities.

The purpose of biopsy is not simply to detect cancer. It is to help define what is happening and guide the next decision properly.

What happens after a prostate biopsy?

The next step depends on the biopsy result and the overall clinical picture.

If the biopsy does not show cancer, further follow-up may still be needed in some situations depending on PSA trends, MRI findings, and ongoing level of suspicion.

If the biopsy shows lower-risk prostate cancer, active surveillance may be appropriate for some patients.

If the biopsy shows clinically significant cancer, treatment options are discussed carefully. This may include surgery, radiation treatment pathways, or other management depending on the individual case.

The key point is that patients should not feel they are facing the result alone. A biopsy result is the beginning of a clearer plan, not the end of the conversation.

Prostate cancer decisions are not one-size-fits-all

Not all prostate cancers behave the same way, and not all patients need the same treatment.

Decisions after biopsy depend on factors such as:

• cancer grade and extent

• PSA level and pattern

• MRI findings

• age and overall health

• personal priorities

• functional considerations such as continence, sexual function, and recovery goals

This is why specialist review matters. The aim is not simply to diagnose prostate cancer, but to guide patients toward the management approach that best fits both the disease and the person.

To learn more about diagnosis and treatment pathways, visit the Prostate Cancer Melbourne page.

Why patients choose Dr Deanne Soares for prostate assessment and biopsy

Dr Deanne is a Melbourne urologist with a strong focus on careful prostate assessment, thoughtful decision-making, and specialist management of prostate conditions, including prostate cancer.

Patients seeking advice about elevated PSA, abnormal MRI findings, or prostate biopsy often value her:

• specialist urological assessment

• careful interpretation of PSA and imaging

• clear explanation of options and next steps

• respectful, no-judgement discussion

• a focus on both accurate diagnosis and what matters to the patient afterwards

For patients who do require treatment, this assessment sits within a broader framework of specialist prostate cancer care, including discussion of surveillance, surgery, and other appropriate options.